Intensifying Regulatory Scrutiny Will Erode Margins Despite Resilient Sectors

AN
AnalystLowTarget
AnalystLowTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
20 Jul 25
Updated
20 Jul 25
AnalystLowTarget's Fair Value
US$100.00
57.8% overvalued intrinsic discount
20 Jul
US$157.77
Loading
1Y
6.2%
7D
2.1%

Author's Valuation

US$100.0

57.8% overvalued intrinsic discount

AnalystLowTarget Fair Value